Mallinckrodt plc v. Airgas Therapeutics LLC - INOmax® (Nitric Oxide)
JD Supra Law
APRIL 29, 2024
Case Name: Mallinckrodt plc v. Airgas Therapeutics LLC, Civ No. 22-1648-RGA, 2024 WL 1251260 (D. Del. Mar. 22, 2024) (Andrews, J.) - Drug Product and Patent(s)-in-Suit: INOmax® (nitric oxide); U.S. Patents Nos. 9,770,570 (“the ’570 patent”), 8,282,966 (“the ’966 patent”), 8,293,284 (“the ’284 patent”), 8,431,163 (“the ’163 patent”), 8,795,741 (“the ’741 patent”), 8,291,904 (“the ’904 patent”), 8,573,209 (“the ’209 patent”), 8,573,210 (“the ’210 patent), 8,776,794 (“the ’6794 patent”), 8,776,795.
Let's personalize your content